• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿激酶和组织型纤溶酶原激活物在胶原诱导性关节炎中的不同作用。

Differing roles for urokinase and tissue-type plasminogen activator in collagen-induced arthritis.

作者信息

Cook Andrew D, Braine Emma L, Campbell Ian K, Hamilton John A

机构信息

Arthritis and Inflammation Research Center, University of Melbourne, Department of Medicine, Victoria, Australia.

出版信息

Am J Pathol. 2002 Mar;160(3):917-26. doi: 10.1016/S0002-9440(10)64914-0.

DOI:10.1016/S0002-9440(10)64914-0
PMID:11891190
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1867189/
Abstract

The plasminogen activators, urokinase PA (u-PA) and tissue-type PA (t-PA), are believed to play important roles in inflammatory cell infiltration, fibrin deposition, and joint destruction associated with rheumatoid arthritis; however, their precise roles in such processes, particularly u-PA, have yet to be defined. Using gene-deficient mice we examined the relative contribution of the PAs to the chronic systemic collagen-induced arthritis model. Based on clinical and histological assessments, u-PA-/- mice developed significantly milder disease and t-PA-/- mice more severe disease compared with the relevant wild-type mice. Fibrin deposition within joints paralleled disease severity and was particularly pronounced in t-PA-/- mice. Likewise, cytokine levels in the synovium reflected the severity of disease, with interleukin-1beta levels in particular being lower in u-PA-/- mice and increased in t-PA-/- mice. The antibody response to type II collagen was normal in both knockouts; however, T cells from u-PA-/- mice had a reduced proliferative response and produced less interferon-gamma on antigen stimulation in vitro. These results indicate that the major effect of u-PA in the collagen-induced arthritis model is deleterious, whereas that of t-PA is protective. Our data highlight the complexities of PA function, and suggest that approaches either to target u-PA or to enhance local t-PA activity in joints may be of therapeutic benefit in rheumatoid arthritis.

摘要

纤溶酶原激活剂,即尿激酶型纤溶酶原激活剂(u-PA)和组织型纤溶酶原激活剂(t-PA),被认为在与类风湿性关节炎相关的炎症细胞浸润、纤维蛋白沉积和关节破坏中发挥重要作用;然而,它们在这些过程中的精确作用,尤其是u-PA的作用,尚未明确。我们使用基因缺陷小鼠研究了纤溶酶原激活剂对慢性系统性胶原诱导性关节炎模型的相对贡献。基于临床和组织学评估,与相关野生型小鼠相比,u-PA基因敲除小鼠的病情明显较轻,而t-PA基因敲除小鼠的病情更严重。关节内的纤维蛋白沉积与疾病严重程度平行,在t-PA基因敲除小鼠中尤为明显。同样,滑膜中的细胞因子水平反映了疾病的严重程度,特别是白细胞介素-1β水平在u-PA基因敲除小鼠中较低,而在t-PA基因敲除小鼠中升高。两种基因敲除小鼠对II型胶原的抗体反应均正常;然而,u-PA基因敲除小鼠的T细胞增殖反应降低,在体外抗原刺激下产生的干扰素-γ也较少。这些结果表明,在胶原诱导性关节炎模型中,u-PA的主要作用是有害的,而t-PA的作用是保护性的。我们的数据突出了纤溶酶原激活剂功能的复杂性,并表明靶向u-PA或增强关节局部t-PA活性的方法可能对类风湿性关节炎具有治疗益处。

相似文献

1
Differing roles for urokinase and tissue-type plasminogen activator in collagen-induced arthritis.尿激酶和组织型纤溶酶原激活物在胶原诱导性关节炎中的不同作用。
Am J Pathol. 2002 Mar;160(3):917-26. doi: 10.1016/S0002-9440(10)64914-0.
2
The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis.纤溶酶原激活物/纤溶酶系统对于II型胶原诱导性关节炎关节炎症期的发展至关重要。
Am J Pathol. 2005 Mar;166(3):783-92. doi: 10.1016/S0002-9440(10)62299-7.
3
Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes.纤溶基因靶向失活的小鼠内皮瘤细胞的纤溶酶原依赖性和非依赖性蛋白水解活性
Thromb Haemost. 1997 Feb;77(2):362-7.
4
The effect of tissue type-plasminogen activator deletion and associated fibrin(ogen) deposition on macrophage localization in peritoneal inflammation.组织型纤溶酶原激活物缺失及相关纤维蛋白(原)沉积对巨噬细胞在腹膜炎症中定位的影响。
Thromb Haemost. 2006 Apr;95(4):659-67.
5
Influence of t-pA and u-PA on adipose tissue development in a murine model of diet-induced obesity.组织型纤溶酶原激活剂(t-pA)和尿激酶型纤溶酶原激活剂(u-PA)对饮食诱导肥胖小鼠模型脂肪组织发育的影响
Thromb Haemost. 2002 Feb;87(2):306-10.
6
Physiological consequences of loss of plasminogen activator gene function in mice.小鼠纤溶酶原激活物基因功能缺失的生理后果。
Nature. 1994 Mar 31;368(6470):419-24. doi: 10.1038/368419a0.
7
Modulation of sympathetic activity by tissue plasminogen activator is independent of plasminogen and urokinase.组织型纤溶酶原激活剂对交感神经活动的调节独立于纤溶酶原和尿激酶。
J Pharmacol Exp Ther. 2007 Jul;322(1):265-73. doi: 10.1124/jpet.107.121335. Epub 2007 Apr 11.
8
Tissue-type plasminogen activator deficiency exacerbates arthritis.组织型纤溶酶原激活物缺乏会加重关节炎。
J Immunol. 2001 Jul 15;167(2):1047-52. doi: 10.4049/jimmunol.167.2.1047.
9
Urokinase-type plasminogen activator and arthritis progression: role in systemic disease with immune complex involvement.尿激酶型纤溶酶原激活物与关节炎进展:免疫复合物参与的全身性疾病中的作用。
Arthritis Res Ther. 2010;12(2):R37. doi: 10.1186/ar2946. Epub 2010 Mar 2.
10
The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro.胰腺癌中的纤溶酶原激活物系统:组织型纤溶酶原激活物在体外侵袭潜能中的作用。
Oncogene. 1998 Feb 5;16(5):625-33. doi: 10.1038/sj.onc.1201564.

引用本文的文献

1
Therapeutics targeting the fibrinolytic system.靶向纤维蛋白溶解系统的治疗方法。
Exp Mol Med. 2020 Mar;52(3):367-379. doi: 10.1038/s12276-020-0397-x. Epub 2020 Mar 9.
2
The multifaceted role of fibrinogen in tissue injury and inflammation.纤维蛋白原在组织损伤和炎症中的多效性作用。
Blood. 2019 Feb 7;133(6):511-520. doi: 10.1182/blood-2018-07-818211. Epub 2018 Dec 6.
3
The Urokinase Plasminogen Activation System in Rheumatoid Arthritis: Pathophysiological Roles and Prospective Therapeutic Targets.
Curr Drug Targets. 2019;20(9):970-981. doi: 10.2174/1389450120666181204164140.
4
Absence of functional compensation between coagulation factor VIII and plasminogen in double-knockout mice.双重基因敲除小鼠凝血因子 VIII 和纤溶酶原之间不存在功能代偿。
Blood Adv. 2018 Nov 27;2(22):3126-3136. doi: 10.1182/bloodadvances.2018024851.
5
A New Explanation of Inflammation in Rheumatoid Arthritis Patients With Respect to Claudin-5, Matrix Metalloproteinase-9, and Neuroserpin.类风湿关节炎患者炎症与闭合蛋白-5、基质金属蛋白酶-9及神经丝氨酸蛋白酶的新解释
Arch Rheumatol. 2016 Aug 1;31(4):299-305. doi: 10.5606/ArchRheumatol.2016.5974. eCollection 2016 Dec.
6
The Coagulation Factors Fibrinogen, Thrombin, and Factor XII in Inflammatory Disorders-A Systematic Review.炎症性疾病中的凝血因子纤维蛋白原、凝血酶和因子 XII:系统评价。
Front Immunol. 2018 Jul 26;9:1731. doi: 10.3389/fimmu.2018.01731. eCollection 2018.
7
Urokinase plasminogen activator and receptor promote collagen-induced arthritis through expression in hematopoietic cells.尿激酶型纤溶酶原激活剂及其受体通过在造血细胞中的表达促进胶原诱导的关节炎。
Blood Adv. 2017 Mar 21;1(9):545-556. doi: 10.1182/bloodadvances.2016004002. eCollection 2017 Mar 28.
8
Deficiency of hyaluronan synthase 1 (Has1) results in chronic joint inflammation and widespread intra-articular fibrosis in a murine model of knee joint cartilage damage.在膝关节软骨损伤的小鼠模型中,透明质酸合酶1(Has1)缺乏会导致慢性关节炎症和广泛的关节内纤维化。
Osteoarthritis Cartilage. 2015 Nov;23(11):1879-89. doi: 10.1016/j.joca.2015.06.021.
9
Porphyromonas gingivalis-derived RgpA-Kgp Complex Activates the Macrophage Urokinase Plasminogen Activator System: IMPLICATIONS FOR PERIODONTITIS.牙龈卟啉单胞菌来源的RgpA-Kgp复合物激活巨噬细胞尿激酶型纤溶酶原激活系统:对牙周炎的影响
J Biol Chem. 2015 Jun 26;290(26):16031-42. doi: 10.1074/jbc.M115.645572. Epub 2015 May 15.
10
GM-CSF and uPA are required for Porphyromonas gingivalis-induced alveolar bone loss in a mouse periodontitis model.在小鼠牙周炎模型中,牙龈卟啉单胞菌诱导的牙槽骨丢失需要GM-CSF和尿激酶型纤溶酶原激活剂。
Immunol Cell Biol. 2015 Sep;93(8):705-15. doi: 10.1038/icb.2015.25. Epub 2015 Mar 10.

本文引用的文献

1
Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease.粒细胞-巨噬细胞集落刺激因子(GM-CSF)抗体对胶原诱导性关节炎发病后的阻断作用:疾病效应阶段对GM-CSF的需求。
Arthritis Res. 2001;3(5):293-8. doi: 10.1186/ar318. Epub 2001 Jun 11.
2
Tissue-type plasminogen activator deficiency exacerbates arthritis.组织型纤溶酶原激活物缺乏会加重关节炎。
J Immunol. 2001 Jul 15;167(2):1047-52. doi: 10.4049/jimmunol.167.2.1047.
3
Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?类风湿关节炎的抗肿瘤坏死因子α治疗:我们学到了什么?
Annu Rev Immunol. 2001;19:163-96. doi: 10.1146/annurev.immunol.19.1.163.
4
Amelioration of collagen-induced arthritis by thrombin inhibition.通过抑制凝血酶改善胶原诱导的关节炎。
J Clin Invest. 2001 Mar;107(5):631-40. doi: 10.1172/JCI11064.
5
Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo.体内高效骨骼肌再生需要尿激酶依赖性纤溶酶原激活。
Blood. 2001 Mar 15;97(6):1703-11. doi: 10.1182/blood.v97.6.1703.
6
The plasminogen activator system: biology and regulation.纤溶酶原激活物系统:生物学与调控
Cell Mol Life Sci. 1999 Oct 1;56(1-2):104-32. doi: 10.1007/pl00000615.
7
Enhanced expression of genes involved in coagulation and fibrinolysis in murine arthritis.
Arthritis Res. 2000;2(6):504-12. doi: 10.1186/ar132. Epub 2000 Sep 20.
8
The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF.集落刺激因子与胶原诱导性关节炎:M-CSF和G-CSF加重疾病以及内源性M-CSF的需求
J Leukoc Biol. 2000 Jul;68(1):144-50.
9
Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis.C57BL/6(H-2b)小鼠胶原诱导性关节炎:类风湿性关节炎重要疾病模型的新见解
Eur J Immunol. 2000 Jun;30(6):1568-75. doi: 10.1002/1521-4141(200006)30:6<1568::AID-IMMU1568>3.0.CO;2-R.
10
Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury.组织型纤溶酶原激活剂介导的纤维蛋白溶解可预防坐骨神经损伤后的轴突退变和脱髓鞘。
J Cell Biol. 2000 May 29;149(5):1157-66. doi: 10.1083/jcb.149.5.1157.